Designating The Month Of October 2025 As Liver Cancer Awareness Month In The State Of Delaware.
Summary
SCR 116 is a concurrent resolution that designates October 2025 as Liver Cancer Awareness Month in Delaware. The resolution states that liver cancer is a rapidly growing cause of cancer deaths, often diagnosed late because it can develop without symptoms, and that awareness is important for prevention, early detection, and support for affected patients and families. It also cites Delaware-specific cancer incidence and mortality data, including elevated late-stage diagnoses in New Castle County, to justify the designation.
The resolution does not create a regulatory program, mandate insurance coverage, or appropriate funding. Instead, it formally recognizes the awareness month and urges Delawareans to learn about liver cancer risk factors, prevention strategies, screenings, and available resources. It also highlights the role of public health agencies, health care providers, and nonprofit organizations in education and outreach.
Impact
SCR 116 has no direct effect on the Delaware Code and does not amend existing statutes. Its practical impact is symbolic and educational: it places the General Assembly on record supporting liver cancer awareness and encourages public health outreach, screening awareness, and community education around liver and intrahepatic bile duct cancers. The resolution may help elevate attention to cancer prevention and early detection efforts, but it does not itself change benefits, reporting requirements, or treatment access for patients.
Sentiment
The sentiment around the resolution appears strongly supportive and noncontroversial. The bill passed the Senate Third Reading unanimously, 20-0, indicating broad bipartisan agreement with the public health message and the recognition of liver cancer awareness month. No committee opposition or recorded debate is provided, and the House vote is listed without yeas or nays, suggesting no visible controversy in the available record.
Contention
There is little apparent contention in the available materials because the measure is a commemorative public health resolution rather than a policy or funding bill. The only substantive emphasis is on the seriousness of liver cancer, the need for early detection, and the role of awareness campaigns; these points are presented as reasons for support rather than disputed issues. No opposing arguments, fiscal concerns, or stakeholder disagreements are reflected in the text or voting history.